Top compounds associated with response to SLC4A3


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.11 0.0008
mRNA Vorinostat gCSI pan-cancer AAC -0.22 0.001
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA SN-38 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.11 0.002
mRNA paclitaxel UHNBreast pan-cancer AAC -0.78 0.003
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.11 0.003
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC 0.14 0.003
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.1 0.003
Download CSV